A proteomics-based approach for the identification of biliary markers of cholangiocarcinoma
Prognosis for patients with cholangiocarcinoma (CCA) continues to be poor as a result of the difficulty in distinguishing malignant from benign bile duct disease, late stage diagnosis and a lack of sufficiently sensitive and specific diagnostic markers. These factors underlie the pressing clinical n...
Main Author: | |
---|---|
Other Authors: | |
Published: |
University of Leeds
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.640631 |